<DOC>
	<DOCNO>NCT00626002</DOCNO>
	<brief_summary>The purpose study evaluate long term safety , efficacy tolerability ABT-874 adult moderate severe psoriasis .</brief_summary>
	<brief_title>Open Label Continuation Study Moderate Severe Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Having participate precede ABT874 clinical trial ABT874 Subject clinical diagnosis moderate severe plaque psoriasis Subjects prematurely discontinue precede psoriasis study ABT874 protocolrequired discontinuation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Open label</keyword>
</DOC>